Form 4: TMO Director Sperling Acquires Phantom Stock Units

Thermo Fisher Scientific director Scott M. Sperling acquired 91.55 phantom stock units valued at $464.24 each as part of a deferred compensation plan.

Summary

• Scott M. Sperling, a Director of Thermo Fisher Scientific Inc. (TMO), acquired 91.55 phantom stock units.
• The transaction occurred on September 27, 2025.
• Each phantom stock unit was valued at $464.24.
• These units were credited to Sperling's account under the Issuer's Deferred Compensation Plan for Directors.
• Directors' retainers are deferred quarterly as Common Stock units based on the closing stock price at quarter-end.
• The phantom stock units are convertible into Common Stock on a 1-for-1 basis.
• Following this transaction, Scott M. Sperling beneficially owns 17,428.67 phantom stock units.
• The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it reflects a director's continued accumulation of company equity through a deferred compensation plan, aligning their interests with shareholders. However, it is a routine, non-discretionary transaction and not indicative of new strategic investment.

Positives

• The acquisition of phantom stock units by a director aligns management's interests with those of shareholders, as the value of these units is tied to the company's stock performance.
• Participation in the Deferred Compensation Plan for Directors indicates a commitment from the director to the company's long-term success.

Future Outlook

The phantom stock units will be distributable as common stock upon the cessation of director service for any reason or in the event of a change of control.

Management Comments

• Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end.

Industry Context

This filing represents a routine insider transaction related to director compensation, which is a standard practice across publicly traded companies to align director incentives with shareholder value. It does not reflect broader industry trends or competitive positioning.

Corporate Governance

Stakeholder Impact

• Shareholders: The transaction increases director Scott M. Sperling's beneficial ownership, which generally aligns his interests with those of other shareholders, potentially leading to decisions that enhance long-term shareholder value.

Next Steps

• The phantom stock units will be distributed as common stock upon the cessation of Scott M. Sperling's director service or a change of control at Thermo Fisher Scientific Inc.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary acquisition of phantom stock units by a director as part of a deferred compensation plan. While it indicates continued alignment of interests, it does not represent a new investment decision based on material non-public information or a significant change in the company's fundamental outlook. Therefore, it does not warrant a change in investment recommendation.

Keywords

Thermo Fisher Scientific, TMO, Scott M. Sperling, Insider Transaction, Form 4, Phantom Stock Units, Deferred Compensation, Director Compensation